(Press-News.org) A global leading cause of death today is a class of dreaded disorders called cardiovascular diseases (CVD), which are ailments of the heart and blood vessels, such as arrhythmia, stroke, coronary artery diseases, cardiac arrest, and so on. The causes for each CVD are different and can be genetic or lifestyle related; but one key risk factor is hypertension, also known as high blood pressure (BP). For instance, as a recent paper published in Chinese Medical Journal notes, in 2017, hypertension was a factor in over 2.5 million deaths in China alone, 95.7% of which were due to CVD.
In this paper, Dr. Jing Liu, expert in the epidemiology of cardiovascular diseases at the Beijing Institute of Heart, Lung, and Blood Vessel Diseases, along with a team of researchers, explores exactly how much hypertension puts a person at significant risk of CVD. As the 2017 statistic shows, the team's study comes at a time when there is a pressing need to make informed decisions on managing hypertension appropriately.
The team began their research at the heels of recent findings in other studies, where it was observed that CVD risk can be elevated for a person even if their BP is below the clinical threshold of hypertension, and having hypertension for longer periods of time, such as several years, can amplify the risk of CVD. So, perhaps, the cumulative BP over a certain period of time, instead of the BP measured at only one point of time, would be a better indicator of the risk of CVD? Studies seemed to indicate as such, but exactly how much cumulative BP meant significant risk of CVD remained a mystery.
To find out, Dr. Liu's team analyzed data from a 26-year follow-up of the Chinese Multi-provincial Cohort Study-Beijing Project. From the data for the first 15 years from 1992 to 2007, they calculated the cumulative BP levels of 2429 participants who were free of CVD at 2007. From the data for 2007 to 2018, the number of CVD incidents among these participants were registered.
Between 2007 to 2018, 207 CVD events had occurred. The incidence of these events was greater among participants with higher cumulative BP. This suggested that cumulative BP was indeed a reliable measure of the risk of CVD.
Further, it appeared that having a cumulative BP level higher than 1970.8/1239.9 mmHg·year--equivalent to maintaining a BP level higher than 131/83 mm/Hg for 15 years--was associated with increased CVD risk. The team had arrived at the elusive threshold value they had set out to find. This value remained true even for participants whose BP values were within limits when measured in 2007. Conversely, if a participant's BP was high in 2007 but their cumulative BP over the 15 years preceding was low, their risk of CVD was low. Thus, cumulative BP was a better indicator of CVD risk than BP measured at one time.
Highlighting a key practical implication of this last finding, Dr. Liu says, "Our findings show that long-term exposure to high blood pressure may increase your risk of cardiovascular disease, although your current blood pressure level is lower than the diagnostic criterion of hypertension. For example, a person with current blood pressure level of 120/70 mmHg, which is within the normal range, could still be at a higher risk of contracting a cardiovascular disease in the future if his/her blood pressure level used to be higher than 130/80 mmHg for a long time, say years, in the past."
"This study underscores the importance of starting BP management early," Dr. Liu continues. Lifestyle changes to keep BP in check, coupled with regular monitoring can go a long way. In addition, waiting to medicate until the BP levels have become chronically high is not wise.
Dr. Liu also suggests a paradigm shift in the way hypertension is monitored by medical professionals. "We wish for our research to guide health care providers to pay attention to a patient's previous blood pressure levels and duration for which BP has been high, in addition to current levels. This will help to identify individuals at a higher risk of cardiovascular disease in the future."
Indeed, if we are to reduce the global burden of cardiovascular diseases, a paradigm shift is just what is needed.
INFORMATION:
Reference
Title of original paper: Association between cumulative blood pressure and long-term risk of cardiovascular disease: findings from the 26-year Chinese Multi-provincial Cohort Study-Beijing Project
Journal: Chinese Medical Journal
DOI: https://doi.org/10.1097/CM9.0000000000001383
Scientists at the University of Southampton have found that a marine invasive species - a sea squirt that lives on rocky shores - could spread along 3,500 kilometres of South American coastline if climate change or human activities alter sea conditions.
The researchers - working with colleagues at Pontificia Universidad Católica de Chile; Flinders University, Australia; University of Johannesburg and Rhodes University, South Africa - analysed the creature's DNA and used predictive modelling to identify regions it could move to and thrive in.1 Findings are published in the journal PNAS.
The team took a multidisciplinary approach to predict the potential distribution of a species that is currently restricted. Studying species with small distributions ...
A new approach to molecular drug design has yielded a highly promising bladder cancer drug, which induced rapid shedding of tumour cells and resulted in a significant reduction in tumour size when used in clinical trials.
These potent effects were seen in patients with non-muscle invasive bladder cancer (NMIBC) and the treatment was shown to be safe, as no drug-related side effects were observed.
The exciting research involved a collaborative group of scientists from Trinity College Dublin, Charles University and Motol Hospital (Prague), Lund University, and startup company Hamlet Pharma. The study has just been published in leading journal Nature Communications.
Bladder cancer - a global killer
Bladder cancer is the fifth most common malignancy in Europe (and the ...
Preliminary results from the European gene therapy trial for Crigler-Najjar syndrome, conducted by Genethon in collaboration with European network CureCN, were presented at the EASL (European Association for the Study of the Liver) annual International Liver Congress on June 26. Based on initial observations, the drug candidate is well tolerated and the first therapeutic effects have been demonstrated, to be confirmed as the trial continues.
Crigler-Najjar syndrome is a rare genetic liver disease characterized by abnormally high levels of bilirubin in the blood (hyperbilirubinemia). This accumulation of bilirubin is caused by a deficiency of the UGT1A1 enzyme, responsible for transforming bilirubin into a substance that can be eliminated by the ...
ATLANTA - JUNE 28, 2021 - A new study finds evidence for adverse effects of the COVID-19 pandemic on declines in cancer detection and surgical treatments. The study, appearing in JNCI: The Journal of the National Cancer Institute, finds a 10.2% decline in real-time electronic pathology reports from population-based cancer registries in 2020 compared with those in 2019.
This study observation period, through December 2020, is one of the longest to date for evaluating the effects of the COVID-19 pandemic on cancer-related trends. To learn more about the indirect effects of the pandemic on cancer care, investigators led by Robin Yabroff, PhD, MBA of the American ...
Up to 7 million people each year receive care in an emergency department (ED) for chest pain, a symptom of a potential heart condition. Over 80 percent of chest pain patients, however, ultimately have no evidence of cardiovascular disease or acute coronary syndrome. To disincentivize patients from over-utilizing costly care, insurers and employers are increasingly opting for high-deductible health plans (HDHPs) that require significant out-of-pocket spending before coverage begins. Researchers from Brigham and Women's Hospital and Harvard Pilgrim Health Care Institute investigated whether ...
The internet is full of dangers: Sensitive data can be leaked, malicious websites can allow hackers to access private computers. The Security & Privacy Research Unit at TU Wien in collaboration with Ca' Foscari University has now uncovered a new important security vulnerability that has been overlooked so far. Large websites often have many subdomains - for example, "sub.example.com" could be a subdomain of the website "example.com". With certain tricks, it is possible to take control of such subdomains. And if that happens, new security holes open up that also ...
The exoplanet satellite hunter CHEOPS of the European Space Agency (ESA), in which the Instituto de Astrofísica de Canarias (IAC) is participating along with other European institutions, has unexpectedly detected a third planet passing in front of its star while it was exploring two previously known planets around the same star. This transit, according to researchers, will reveal exciting details about a strange planet "without a known equivalent".
The discovery is one of the first results of CHEOPS (CHaracterising ExOPlanet Satellite) and the first time that an exoplanet has been seen with a period longer than 100 days transiting a star which is sufficiently ...
Scientists of Tomsk Polytechnic University were able to obtain polytetrafluoroethylene (PTFE) membranes using electrospinning. PTFE is known to be the most stable existent polymer. According to the scientists, it is a simple, affordable and easily scalable method, which will allow obtaining chemically stable membranes in industrial-scale production. The membranes can be used in petrochemical, aerospace, nuclear industries, carbon-free energy and medicine.
The latest results of the research of physical and chemical properties and biocompatibility of the obtained membranes are published ...
The U.S. Food and Drug Administration's controversial decision to approve aducanumab for the treatment of Alzheimer's disease raises at least three major ethical issues that need to be addressed, states a new article in the Hastings Center Report:
Billions of dollars in Medicare resources (which is to say, taxpayer dollars) are at risk of being unjustly squandered.
Physicians must choose between facilitating this unjust squandering and denying desperate patients and families access to this drug.
Patients and families are having false hopes legitimated and encouraged when physicians prescribe aducanumab.
The drug's approval was contrary to the nearly unanimous judgment of an FDA advisory committee that there was little reliable evidence of significant ...
HOUSTON - (June 28, 2021) - Rice University computer scientists are sending RAMBO to rescue genomic researchers who sometimes wait days or weeks for search results from enormous DNA databases.
DNA sequencing is so popular, genomic datasets are doubling in size every two years, and the tools to search the data haven't kept pace. Researchers who compare DNA across genomes or study the evolution of organisms like the virus that causes COVID-19 often wait weeks for software to index large, "metagenomic" databases, which get bigger every month and are now measured in petabytes.
RAMBO, which is short for "repeated and merged bloom filter," is a new method that can cut indexing times for such ...
